Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.65
Bid: 18.40
Ask: 19.65
Change: 0.775 (4.11%)
Spread: 1.25 (6.793%)
Open: 19.65
High: 19.65
Low: 19.65
Prev. Close: 18.875
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

27 Feb 2012 07:00

RNS Number : 1344Y
BATM Advanced Communications Ld
27 February 2012
 



 

BATM Advanced Communications Limited

 

Preliminary results for 2011

 

BATM Advanced Communications Limited ("BATM" or "the Company") (LSE: BVC), a leading designer and producer of broadband data and telecoms systems and medical laboratory equipment, announces its preliminary results for the year ended 31 December 2011.

 

Highlights

 

·; Overall revenue growth of 6% with organic revenue growth of 14% delivered in Medical division

·; Telecom division gross margin (excluding write offs related to legacy business) increased by 3% over 2010 and slight increase in Medical gross margin from 20.6% to 21.4%

·; Development of Medical division continues but year adversely affected by slower than anticipated certifications

·; Balance sheet remains strong with $47 million net cash

·; Telco legacy business to be wound down to focus on IP growth resulting in one off costs of $5.3m

 

 

Full Year Highlights

 

Year ended 31 December

2011

2010

Change %

Revenue

$127.6m

$120.6m

5.80%

Gross profit

$43.4m

$42.7m

1.64%

Adjusted Operating Profit(*)

$5.6m

$5.6m

Other operating expenses

$6.72m

$4.52m

49%

Profit (loss) for the period (after write off of legacy business)

 

$(5.0)m

 

$0.2m

 

 

Earnings/ (loss) per share (basic)

 (0.92)c

0.42c

(*) excluding other operating expenses and stock write-down related to telecom legacy business of $2.2m in 2011

 

 

 

Dr Zvi Marom, Chief Executive of BATM said:

 

"Despite a weak trading environment in 2011 and adverse currency fluctuations I am encouraged to be able to report increases in both revenues and the gross profits of the business.

 

The Board has, following the review announced on 12 December 2011, decided to make structural changes to our Telecom division by curtailing certain legacy business lines. The positive results of this re-organisation are already being felt in 2012.

 

In addition we are introducing a number of new products and services both in the Telecom and Medical divisions that should provide positive ongoing growth prospects.

 

I thank our management team and staff at all levels for their efforts and shareholders for their continued support."

 

 

 

 

For further information please contact: 27 February Thereafter

 

BATM Advanced Communications Limited

Dr Zvi Marom, Chief Executive 020 7653 9850 00972 9 866 2525

Ofer Bar-Ner, Chief Financial Officer 020 7653 9850 00972 9 866 2525

 

finnCap

Marc Young / Brian Patient 020 7220 0500 020 7220 0500

 

Shore Capital

Pascal Keane 020 7408 4090 020 7408 4090

 

Newgate Threadneedle

Josh Royston / Graham Herring 020 7653 9850 020 7653 9850

 

 

 

Chairman's Statement

 

 

General review

 

BATM has come through a difficult year given the adverse effects of both ongoing global economic turmoil and a rapidly changing competitive environment, with results that management has hoped to exceed but with positive signs that the strategy we have adopted remains the key to a return to growth and profitability. The board has conducted a thorough review of every segment of our business and stands firmly behind the continued development of the Telecom and Medical divisions.

 

Financial Review

 

Revenues for the year of 2011 increased by $7 million to $127.6 million (2010: $120.6 million). Telecom division revenues increased 2% to $81.3 million (2010: $79.9 million) and Medical division revenues increased 14% to $46.3 million (2010: $40.7 million). Revenues from the telecom legacy business were $16.9 million representing 21% of the total telecom revenues. As a result of the decision to curtail the legacy telecoms business the Company has taken one off charges to the income statement totalling $5.3 million being made up of a stock write down of $2.2million reflected in cost of sales, severance payments of $0.1 million and a $3.0 million charge relating to amortisation of intangibles reflected within other operating expenses.

 

 

Overall gross profit margin for the year of 2011 was 34.0% (2010: 35.4%). The decrease was mostly due to a year end write off of $2.2 million inventory related to the telecom legacy business, which is being discontinued and excluding this one off charge margins increased by 1.7%. The gross profit margin of the Telecom division for the year 2011 was 41.2% (2010: 42.9%). The gross profit margin of the Medical division for the year of 2011 was 21.4% (2010: 20.6%). A gross profit margin of 22% in the Medical division in the second half of 2011 reflected a positive trend and compared with 21% in H1 2011.

 

Sales and marketing expenses were $16.3 million (2010: $15.3 million), an increase of 6.5% over the previous year. The increase is mostly due to an increase of $2 million in distribution and sales costs in the Medical division offset by a decrease of $1 million in the sales expenses in the Telecom division.

 

General and administrative expenses were $10.5 million (2010: $9.2 million) an increase of $1.3 million, mostly in the Telecom division. The erosion of the average rate of US dollar to the shekel plus costs associated with strengthening the top management of Telco Systems were the main contributors.

 

R&D investment in 2011 was $13.2 million (2010: $12.5 million). Actual R&D expenses in 2011 were lower than 2010 by $0.2 million, however, 2010 expenses were offset by $0.9 million participation from the Israeli Chief Scientist compared with nil in 2011. Medical division R&D expenses increased by $0.4 million mostly in the area of Diagnostic products.

 

Adjusted operating profit for the year was $5.6m (2010: $5.6m) (adjusted for the impact of one off stock depreciation linked to the curtailment of legacy telecoms activities). Operating profit for the year before other operating expenses was $3.4 million (2010: profit of $5.6 million). After other operating expenses of $6.7 million (2010: $4.5 million) including a $3.0 million charge to write off the remaining intangible assets associated with certain legacy products of the Telecom division, the net operating loss was $3.3 million (2010: profit $1.1 million).

 

Net finance expenses were $0.8 million ( 2010: expenses $0.1 million), comprised of $0.9 million of interest income, as well as $0.2 million of forward transaction gains, which offset $1.2 million of foreign exchange losses and $0.7 million of finance costs related mostly to bank loans. The finance costs include $0.3 million of interest on a mortgage of our subsidiary in Italy that is expected to be cancelled in 2012. As a result of our lower revenues in Euros, BATM has reverted back to the US dollar as its functional currency, representing the primary economic operating environment of the company.

 

The majority of Tax expenses of $0.9 million are $0.7 million tax on the dividend paid in 2011 of $5.1 million.

 

Net loss after tax attributable to equity holders of the parent amounted to $3.7 million (2010: profit $1.7 million), resulting in a basic loss per share of 0.92¢ (2010 earning: 0.42¢).

 

Our balance sheet remains strong with effective liquidity of $46.9 million, reflecting a decrease of $7.8 million since the end of the first half of the year. The reduction in the cash balances is mainly a result of the dividend payment of $5.8 million and payments on our properties in Israel and in Italy of $2.0 million. These payments resulted in a reduction in both short term and long term debt of $0.5 million and $4.2 million respectively. Period end cash is comprised as follows: cash and deposits up to three months duration of $23.0 million; short term cash deposits up to one year of $23.9 million.

 

Intangible assets and Goodwill have decreased to $26.2 million (December 2010: $31.1 million). This decrease results from the amortization of intangible assets and the write off of intangible assets relating to certain legacy products in the Telecom division.

 

Property, plant and equipment at the end of 2011 remained substantially unchanged compared with the end of 2010.

 

Total inventories increased from $19.5 million at the end of 2010 and decreased from $26.3 million at the end of June 2011 to $24.3 million at the year-end 2011.The majority of the increase relates to the Telecoms division, where stocks have been increased to satisfy the growing demand for our new products. In addition, Medical division inventory has been increased to prepare for the launch of our new medical waste solution (ISS) in 2012.

 

Trade and other receivables at the end of 2011 decreased to $27.5 million from $30.9 million at the end of 2010. This decrease is largely due to decreased receivables in the Telecom division. Total liabilities decreased to $45.3 million at the end of 2011 from $49.9 million at the end of 2010. The majority of the decrease relates to the cash payments described above.

 

 

 

 

 

Business Review

 

Telecom Division

 

As reported in December, trading in our legacy business in the US has been below our expectations. Following a detailed strategic review, we have decided to separate the legacy products group in the US from the Telecom division and exit this part of our business during 2012.

 

In April, we announced the acquisition of the major assets of ANDA Networks. Following the acquisition, we began serving ANDA's existing client base and have re-branded the former ANDA products as Telco Systems products. The existing customers' business will stay with the legacy business while the same products under Telco Systems brand will continue to be offered as part of our Carrier Ethernet solutions.

 

In May, we announced the appointment of Itzik Weinstein as CEO of Telco Systems. Prior to joining us, Itzik served as CEO of ECtel, a provider of revenue management solutions to the telecommunications industry and a NASDAQ traded company. He is responsible for driving the growth in our Carrier Ethernet offering and will be directing a higher focus on our direct business in Europe and the Far-east.

 

As reported in October and November, our Telecom division secured two important new OEM agreements; one with Motorola Mobility and one with the largest tier 1 telecom vendor. The agreement with Motorola will allow them to help cable operators leverage their HFC infrastructure to provide complete solutions for commercial services. We have already started generating business from this agreement and expect this to grow significantly during 2012. The agreement with the tier 1 telecom vendor is currently focused on the business demarcation product line and is expected to contribute revenues in 2012.

 

 

Medical Division

 

Our distribution business continues to grow and perform as expected. We are now looking to expand it further into Bulgaria with the help of one of our major diagnostic vendors. We expect this move to have a positive contribution beginning in the second half of 2012.

Our sterilization business managed to finish strongly in 2011. We expect this trend to continue into 2012. The sales of the Integrated Shredder Sterilizer (ISS) to treat medical waste exceeded our revenue expectations, which were reported in the interim results. We continue to expand our marketing efforts on the success of this new product. In addition, we have recently received certification to sell our sterilizers in the domestic market in Israel. We plan to take advantage of these early successes for increased revenue in 2012.

The diagnostics business continues to require the vast majority of our investment in the Medical division and continued to make significant losses. As reported, the process to complete testing, certification and manufacturing will continue at least until the end of 2012. In the meantime, we remain fully committed to make the necessary investment and are confident that by 2013 we will start seeing the results of these investments. This business has considerable potential and we will continue to monitor its progress closely to ensure that the potential is maximised.

Registration of Shares in Tel-Aviv

 

Following our last update we received approval to delay our listing on the Tel-Aviv Stock Exchange The Board has now decided to move ahead and hope to have a dual listing before the end of the first-half of 2012. We believe that this move will improve both visibility of the company and opportunities which may benefit the Company and its shareholders.

 

 

 

 Dividends

In light of the results for the year and the Israeli Companies Law that permits distribution of dividends only from net profits during the last 2 years, the Board is not proposing the payment of a dividend for the year. We remain confident that we will be able to return to our progressive dividend policy as the results of our trading strategy produce the anticipated results.

 

 

Current Trading and Prospects

 

The initial indications from our first month of trading in 2012 are in line with our expectations. We are seeing continued progress in our Medical division and a reduction in legacy business in our Telecom division. Whilst this trend is likely to continue during the early months of 2012 we anticipate that our new business opportunities and products will start to have an increasing impact and although the full benefit is unlikely to become evident until next year, subject to the major world economic factors over which we have no control, we have every prospect of producing a significantly improved result for the year as a whole.

 

Peter Sheldon

Chairman

 

27 February 2012

 

 

 

BATM ADVANCED COMMUNICATIONS LTD.

CONSOLIDATED INCOME STATEMENTS

Year ended 31 December

2 0 1 1

2 0 1 0

US$ in thousands

Revenues

127,634

120,578

Cost of revenues

84,226

77,905

Gross profit

43,408

42,673

------------

------------

 Operating expenses

Sales and marketing expenses

16,284

15,332

General and administrative expenses

10,495

9,241

Research and development expenses

13,194

12,450

Other operating expenses

6,715

4,517

Total operating expenses

46,688

41,540

------------

------------

 Operating profit (loss)

(3,280)

1,133

Finance income

1,126

1,549

Finance expenses

(1,928)

(1,652)

Profit / (loss) before tax

(4,082)

1,030

Income tax

(885)

(836)

 Profit / (loss) for the year

(4,967)

194

Attributable to:

Owners of the Company

(3,720)

1,699

Non-controlling interests

(1,247)

(1,505)

Income / (loss) for the period

(4,967)

194

Earnings / (loss) per share (in cents) basic

(0.92)

0.42

Earnings / (loss) per share (in cents) diluted

(0.92)

0.42

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

Year ended 31 December

2 0 1 1

2 0 1 0

US$ in thousands

Profit / (loss) for the year

(4,967)

194

Exchange differences on translating foreign operations

 (1,621)

(4,911)

Total Comprehensive loss of the Year

(6,588)

(4,717)

Attributable to:

Owners of the Company

(6,287)

(4,312)

Non-controlling interests

(301)

(405)

(6,588)

(4,717)

BATM ADVANCED COMMUNICATIONS LTD.

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

 

31 December

 

2 0 1 1

2 0 1 0

 

US$ in thousands

 

Non-current assets

 

 

Goodwill

 

11,616

 

11,300

 

Other intangible assets

Property, plant and equipment

Deferred tax asset

14,539

25,153

5,525

19,798

25,943

5,122

 

56,833

62,163

 

 

Current assets

 

Inventories

24,297

19,470

 

Financial assets

23,883

38,079

 

Trade and other receivables

27,529

30,900

 

Cash and cash equivalents

23,012

22,087

 

98,721

110,536

 

 

 

 

Total assets

155,554

172,699

 

 

Current liabilities

Short-term bank credit

Trade and other payables

Provisions

 

 

 

6,770

27,441

2,507

36,718

 

 

6,135

27,900

_ 3,190 

37,225

 

Net current assets

62,003

73,311

 

 

Non-current liabilities

Long-term payables

 

7,557

 

11,840

 

Retirement benefit obligation

 

Total liabilities

1,001

_ 8,558

45,276

 

884

______12,724

49,949

 

 

Net assets

110,278

122,750

 

 

Equity

 

Share capital

1,215

1,215

 

Share premium account

406,892

406,504

 

Foreign currency translation reserve and other reserves

 

(13,073)

 

(8,798)

 

 Accumulated Deficit

(286,088)

(277,236)

 

Equity attributable to equity holders of the:

 

Owners of the Company

108,946

121,685

 

Non-controlling interest

1,332

1,065

 

Total equity

110,278

122,750

 

 

BATM ADVANCED COMMUNICATIONS LTD.

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

 

 

Year ended on 31 December 2011

 

 

Share Capital

Share Premium Account

 

Translation reserve

 

Other

reserve

 

Accumulated

Deficit

 

Attributable to owners of the parent

 

Non-Controlling Interests

 

Total

equity

US$ in thousands

As at 1 January 2011

 

 

1,215

 

 

406,504

 

 

(10,026)

 

 

1,228

 

 

(277,236)

 

 

121,685

 

 

 

1,065

 

 

122,750

Exercise of share based options by employees

 

 

 

-

 

 

 

62

 

 

 

62

 

 

 

-

 

 

 

62

Recognition of share-based payments

 

 

326

 

 

326

 

 

-

 

 

326

Purchase of non- controlling interest

 

 

 

(889)

 

 

 

(819)

 

 

 

(1,708)

 

 

 

568

 

 

 

(1,140)

 

Dividend

 

(5,132)

 

(5,132)

 

-

 

(5,132)

 Comprehensive loss for the year

 

-

 

-

(2,567)

-

 

(3,720)

(6,287)

 

(301)

 

(6,588)

As at 31 December 2011

 

 

1,215

 

 

406,892

 

 

(13,482)

 

 

409

 

 

(286,088)

 

 

108,946

 

 

1,332

 

 

110,278

 

BATM ADVANCED COMMUNICATIONS LTD.

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (cont.)

 

Year ended on 31 December 2010

 

 

Share Capital

Share Premium Account

 

Translation reserve

 

Other

reserve

 

Accumulated

Deficit

 

Attributable to owners of the parent

 

Non-Controlling Interests

 

Total

equity

US$ in thousands

As at 1 January 2010

 

 

1,214

 

 

405,961

 

 

(4,015)

 

 

786

 

 

(270,808)

 

 

133,138

 

 

 

1,912

 

 

135,050

Exercise of share based options by employees

 

 

 

1

 

 

 

117

 

 

 

118

 

 

 

-

 

 

 

118

Recognition of share-based payments

 

 

426

 

 

426

 

 

-

 

 

426

Purchase of non- controlling interest

 

 

 

442

 

 

 

442

 

 

 

(442)

 

 

 

-

 

Dividend

 

(8,127)

 

(8,127)

 

 

-

 

(8,127)

 

Comprehensive loss for the year

 

-

 

-

 

(6,011)

__-

 

1,699

 

(4,312)

 

(405)

 

(4,717)

As at 31 December 2010

 

 

1,215

 

 

406,504

 

 

(10,026)

 

 

__1,228

 

 

(277,236)

 

 

121,685

 

 

1,065

 

 

122,750

 

BATM ADVANCED COMMUNICATIONS LTD.

CONSOLIDATED STATEMENT OF CASH FLOWS

 

Year ended 31 December

 2 0 1 1

2 0 1 0

US$ in thousands

Net cash from operating activities  (Appendix A)

3,138

12,481

-------------

-------------

Investing activities

 

Interest received

Proceeds on forward transactions

Proceeds on disposal of held to maturity investments

Proceeds on disposal of property, plant and equipment

Proceeds on disposal of financial assets carried at fair value through profit and loss

Proceeds on disposal of deposits

 

887

-

-

134

 

6,515

46,150

 

612

1,154

4,316

-

 

13,108

38,427

Purchases of property, plant and equipment

Purchases of forward transaction

Purchases of financial assets carried at fair value through profit and loss

Purchases of deposits

(1,672)

-

 

-

(41,647)

(6,392)

 (1,099)

 

(20,221)

(39,727)

Net Cash outflow on acquisition of business combinations

 (3,418)

(171)

Net cash from (used in) investing activities

6,949

(9,993)

-------------

-------------

Financing activities

Dividends paid to owners of the Company

Tax on dividend

Increase (decrease) in short-term bank credit

(5,132)

(694)

366

(8,127)

(637)

(1,761)

Bank loan received

-

1,500

Bank loan repayment

(2,717)

(1,032)

Purchase of non-controlling interest

(767)

-

Proceeds on issue of shares

62

118

Net cash used in financing activities

(8,882)

(9,939)

-------------

-------------

Increase (decrease) in cash and cash equivalents

1,205

(7,451)

Cash and cash equivalents at the beginning of the Year

 

22,087

 

28,095

Effects of exchange rate changes on the balance of cash held in foreign currencies

 

(280)

 

1,443

Cash and cash equivalents at the end of the Year

23,012

22,087

BATM ADVANCED COMMUNICATIONS LTD.

APPENDICES TO CONSOLIDATED STATEMENT OF CASH FLOWS

 

APPENDIX A

RECONCILIATION OF OPERATING PROFIT (LOSS) FOR THE YEAR TO NET CASH

FROM OPERATING ACTIVITIES

Year ended 31 December

2 0 1 1

2 0 1 0

US$ in thousands

Operating profit (loss) from - operations

Adjustments for:

(3,280)

1,133

Amortization of intangible assets

3,743

3,738

Write off of intangible assets and goodwill

2,972

-

Depreciation of property, plant and equipment

2,055

2,482

Stock options granted to employees

326

426

Increase in retirement benefit obligation

117

41

Decrease in provisions

(312)

(898)

Operating cash flow before movements in working capital

5,621

6,922

Decrease (Increase) in Inventory

(4,337)

1,959

Decrease (Increase) in receivables

3,720

(480)

Increase (decrease) in payables

(723)

4,466

Cash generated by operations

4,281

12,867

Income taxes paid

(626)

(338)

Income taxes received

Interest paid

-

 (517)

378

(426)

Net cash from operating activities

3,138

12,481

 

BATM ADVANCED COMMUNICATIONS LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Note 1 - General

 

The preliminary results for the year ended 31 December 2011 and the comparative 2010 information will presented in the full Annual report in accordance with International Financial Reporting Standards ("IFRS").

 

 

Note 2 - Profit (loss) per share

 

Profit (loss) per share is based on the weighted average number of shares in issue for the year of 402,872,861 (2010: 402,494,652). The number used for the calculation of the diluted profit per share for the year (which includes the effect of dilutive stock option plans) is -402,872,861 shares (2010: 403,222,832).

 

Note 3 - Significant events during the reporting period

 

On January 23, 2011 the company signed an agreement with the minority shareholders in part of the medical division to purchase their holding of 25%. The consideration is as follows: Cash of $1.159 million and a small percentage of the future receipts from the medical division, estimated at $364,000 as of 31 December, 2011.

 

In April, 2011, the Company acquired the trade and assets of an Israeli telecom software services provider called Mantis Ltd ("Mantis") for consideration of $0.8 million.

 

In April, 2011, the Company acquired the major assets and intellectual property of ANDA Networks, Inc. ("ANDA") for consideration of $2.0 million.

 

As at the date of this preliminary results statement, the Purchase Price Allocation ("PPA") of ANDA and Mantis had not been completed. Accordingly, the allocation used for these financial statements represents management's best estimates.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BATM ADVANCED COMMUNICATIONS LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

 

Note 4 - Segments

 

Business Segment

 

Year ended 31 December 2011

 

Telecommunications

 

Medical

 

Total

US$ in thousands

Revenues

81,320

46,314

127,634

Operating profit (loss)(*)

6,857

(3,422)

3,435

 

 

 

Year ended 31 December 2010

 

Telecommunications

 

Medical

 

Total

US$ in thousands

Revenues

79,877

40,701

120,578

Operating profit (loss)(*)

7,834

(2,184)

5,650

 

(*) Excluding other operating expenses

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR UNUKRUBAUUAR
Date   Source Headline
2nd May 20247:00 amRNSBATM selected for TB diagnostics programme
18th Apr 20247:00 amRNSBATM to deliver Edgility to new Tier 1 customer
8th Apr 20247:00 amRNSBATM awarded new Edgility contract from Cemex
3rd Apr 20247:00 amRNSAnnual Financial Report
26th Mar 20247:00 amRNSBATM receives $2.3m cyber security orders
12th Mar 20247:00 amRNSFull Year Results
29th Feb 20247:00 amRNSNotice of Results
2nd Jan 20247:00 amRNSTotal Voting Rights
30th Nov 20237:03 amRNSBlock Listing Application
27th Nov 20237:00 amRNSBlock Listing Interim Review
30th Oct 20237:00 amRNSBATM receives $3m cyber security order
23rd Oct 20237:00 amRNSADOR Diagnostics secures $7.5m investment
16th Oct 20233:30 pmRNSHolding(s) in Company
16th Oct 20233:30 pmRNSHolding(s) in Company
16th Oct 20237:00 amRNSNew Edgility order for US Emergency Services
9th Oct 20237:00 amRNSResponse to recent developments in Israel
6th Sep 20237:00 amRNSBATM receives $3.4m cyber security contract
29th Aug 20237:00 amRNSInterim Results
13th Jul 202311:30 amRNSResult of AGM and Director Appointment
8th Jun 20237:00 amRNSNotice of Annual General Meeting
6th Jun 20237:00 amRNSCapital Markets Day
5th Jun 20237:00 amRNSNew contract win for Edgility
10th May 20232:30 pmRNSCapital Markets Day and Investor Presentation
17th Apr 20237:00 amRNSEdgility rollout progressing ahead of schedule
4th Apr 20233:30 pmRNSAnnual Financial Report
6th Mar 20237:00 amRNSFull Year Results
24th Feb 20237:00 amRNSNotice of Results
1st Feb 20237:00 amRNSAppointment of Chief Financial Officer
9th Jan 20237:00 amRNSBATM receives $26m cyber security order
3rd Jan 20233:30 pmRNSGrant of Options
21st Dec 202212:00 pmRNSResult of AGM
21st Dec 20227:00 amRNSTransaction in Own Shares and TVR
20th Dec 20227:00 amRNSTransaction in Own Shares and TVR
19th Dec 20227:00 amRNSTransaction in Own Shares and TVR
16th Dec 20227:00 amRNSTransaction in Own Shares and TVR
15th Dec 20227:00 amRNSTransaction in Own Shares and TVR
14th Dec 20227:00 amRNSTransaction in Own Shares and TVR
13th Dec 20227:00 amRNSTransaction in Own Shares and TVR
9th Dec 20227:00 amRNSTransaction in Own Shares and TVR
8th Dec 20227:00 amRNSTrading Update
25th Nov 20221:00 pmRNSBlock Listing Interim Review
24th Nov 20224:00 pmRNSNotice of Annual General Meeting
27th Oct 20227:00 amRNSADOR and BIOASTER to develop STI diagnostic tests
18th Oct 20227:00 amRNSMulti-year contract with CityFibre for Edgility
6th Oct 20227:00 amRNSDirectorate Changes
24th Aug 20227:00 amRNSInterim Results
19th Jul 20227:00 amRNSAppointment of CEO of ADOR Diagnostics
11th Jul 20227:00 amRNSBATM partners with CityFibre for Edgility
16th Jun 20224:36 pmRNSPrice Monitoring Extension
26th May 20227:00 amRNSBlock Listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.